Niu, Y., Lin, A., Luo, P., Zhu, W., Wei, T., Tang, R., . . . Zhang, J. (2020). Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors. Front Pharmacol.

Niu, Yuchun, Anqi Lin, Peng Luo, Weiliang Zhu, Ting Wei, Ruixiang Tang, Linlang Guo, and Jian Zhang. "Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors." Front Pharmacol 2020.

Niu, Yuchun, et al. "Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors." Front Pharmacol 2020.